ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $33,348,000 | -1.7% | 38,110,000 | 0.0% | 0.04% | -2.6% |
| Q1 2016 | $33,939,000 | -10.8% | 38,110,000 | +15.1% | 0.04% | -9.3% |
| Q4 2015 | $38,056,000 | +14.2% | 33,110,000 | -9.6% | 0.04% | +16.2% |
| Q3 2015 | $33,326,000 | -10.0% | 36,610,000 | 0.0% | 0.04% | +5.7% |
| Q2 2015 | $37,043,000 | +21.7% | 36,610,000 | +22.4% | 0.04% | +20.7% |
| Q1 2015 | $30,439,000 | -19.4% | 29,900,000 | -9.1% | 0.03% | -19.4% |
| Q4 2014 | $37,785,000 | +7.5% | 32,900,000 | -3.2% | 0.04% | +2.9% |
| Q3 2014 | $35,161,000 | – | 34,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |